104 related articles for article (PubMed ID: 2905241)
1. A comparison of roxatidine acetate 150 mg once daily and 75 mg twice daily in gastric ulcer healing.
Rösch W
Drugs; 1988; 35 Suppl 3():127-33. PubMed ID: 2905241
[TBL] [Abstract][Full Text] [Related]
2. A comparison of roxatidine acetate 150 mg once daily and 75 mg twice daily in duodenal ulcer healing.
Hentschel E; Schütze K
Drugs; 1988; 35 Suppl 3():96-101. PubMed ID: 2905256
[TBL] [Abstract][Full Text] [Related]
3. A comparison of roxatidine acetate and ranitidine in gastric ulcer healing.
Judmaier G
Drugs; 1988; 35 Suppl 3():120-6. PubMed ID: 2905240
[TBL] [Abstract][Full Text] [Related]
4. A comparison of roxatidine acetate and ranitidine in duodenal ulcer healing.
Hüttemann W
Drugs; 1988; 35 Suppl 3():90-5. PubMed ID: 2905255
[TBL] [Abstract][Full Text] [Related]
5. Clinical studies on the use of roxatidine acetate for the treatment of peptic ulcer in Japan.
Inoue M
Drugs; 1988; 35 Suppl 3():114-9. PubMed ID: 2905239
[TBL] [Abstract][Full Text] [Related]
6. Roxatidine acetate in the long term maintenance of gastric ulcers.
Börsch G
Drugs; 1988; 35 Suppl 3():134-8. PubMed ID: 2905242
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of roxatidine acetate. Evidence from pharmacodynamic and clinical trials.
Merki HS; Bender W; Labs R
J Clin Gastroenterol; 1989; 11 Suppl 1():S20-3; discussion S24. PubMed ID: 2572621
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of roxatidine acetate: a review.
Dammann HG; de Looze SM; Bender W; Labs R
Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, randomized, double-blind comparison of roxatidine with ranitidine in the treatment of patients with uncomplicated benign gastric ulcer disease. The Multicenter Roxatidine Cooperative Study Group.
Brandstätter G; Marks IN; Lanza F; Kogut D; Cobert B; Savitsky JP; Bender W; Labs R; Wurzer H
Clin Ther; 1995; 17(3):467-78. PubMed ID: 7585851
[TBL] [Abstract][Full Text] [Related]
10. Roxatidine acetate as maintenance treatment for patients with peptic ulcer disease. The European Cooperative Roxatidine Study Group.
Clin Ther; 1991; 13(1):47-57. PubMed ID: 1674231
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer disease. Multicenter Roxatidine Cooperative Study Group.
Gilinsky NH; Bright-Asare P; Cobert BL; Fitch DD; Lanza FL; Kerr RM; Savitsky JP
Am J Gastroenterol; 1992 Jul; 87(7):847-53. PubMed ID: 1352083
[TBL] [Abstract][Full Text] [Related]
12. Roxatidine versus ranitidine in the treatment of patients with duodenal ulcer: a randomized, double-masked, multicenter study.
Zuberi SJ; Khan AQ; Irshad-ul-Haque I; Hussain A; Hasnain SS; Shah S; Sadick A; Yusuf MZ; Reuter M
Clin Ther; 1996; 18(6):1207-12. PubMed ID: 9001837
[TBL] [Abstract][Full Text] [Related]
13. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
[TBL] [Abstract][Full Text] [Related]
14. Roxatidine in duodenal ulcer.
Habibullah CM; Habeeb MA; Singh SP
J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
[TBL] [Abstract][Full Text] [Related]
15. New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer.
Amarapurkar DN; Parikh SS; Desai HG
J Assoc Physicians India; 1993 Aug; 41(8):496-7. PubMed ID: 7904993
[TBL] [Abstract][Full Text] [Related]
16. Determining the optimal dosage regimen for H2-receptor antagonist therapy--a dose validation approach.
Young MD; Frank WO; Dickson BD; Peace KP; Braverman A; Mounce W
Aliment Pharmacol Ther; 1989 Feb; 3(1):47-57. PubMed ID: 2577482
[TBL] [Abstract][Full Text] [Related]
17. Roxatidine acetate in the long term maintenance of duodenal ulcers.
Brunner G
Drugs; 1988; 35 Suppl 3():102-5. PubMed ID: 2905238
[TBL] [Abstract][Full Text] [Related]
18. Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healing.
McCullough AJ; Graham DY; Knuff TE; Lanza FL; Levenson HL; Lyon DT; Munsell WP; Perozza J; Roufail WM; Sinar DR
Gastroenterology; 1989 Oct; 97(4):860-6. PubMed ID: 2570730
[TBL] [Abstract][Full Text] [Related]
19. [Early evening and late evening administration of roxatidine acetate in therapy of duodenal ulcer].
Bosseckert H; Ernst R; Kriech W; Schunter C
Med Klin (Munich); 1993 Nov; 88(11):637-41. PubMed ID: 7905185
[TBL] [Abstract][Full Text] [Related]
20. The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men.
Lassman HB; Ho I; Puri SK; Sabo R; Scheffler MR
Drugs; 1988; 35 Suppl 3():53-64. PubMed ID: 2905250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
